Table 1.
Association of serum miR-183 with clinicopathological variables in 75 patients with epithelial ovarian cancer
| Variables | miR-183 expression | P-value | |
|---|---|---|---|
|
| |||
| Low miR-183 (N=36) N (%) | High miR-183 (N=39) N (%) | ||
| Age (years) | |||
| < 50 | 27 (75.0%) | 28 (71.8%) | 0.539 |
| ≥ 50 Clinical Stage | 9 (25.0%) | 11 (28.2%) | |
| Stage I/II | 25 (69.4%) | 9 (23.1%) | 0.008* |
| Stage III/IV | 11 (30.6%) | 30 (76.9%) | |
| Histology | |||
| Serous | 11 (30.6%) | 8 (20.5%) | 0.533 |
| Mucinous | 15 (41.7%) | 19 (48.7%) | |
| Other | 10 (27.7%) | 12 (30.8%) | |
| Histological Grade | |||
| 1 | 12 (34.4%) | 15 (38.5%) | 0.178 |
| 2 | 17 (47.2%) | 17 (43.6%) | |
| 3 | 7 (19.4%) | 7 (17.9%) | |
| Lymph node metastases | |||
| Negative | 24 (66.7%) | 14 (35.9%) | 0.011* |
| Positive | 12 (33.3%) | 25 (64.1%) | |
*
P < 0.05.